Insurers are a major determinant of access, sometimes limiting use to specific diagnoses or patient populations
This will position your body to reduce straining
In Feb26, Hernexeos (zongertinib) received FDA accelerated approval for advanced HER2-mutant NSCLC, based on a 76% objective response rate (N=72) in the Beamion LUNG-1 study, following Breakthrough Therapy Designation and prior approval in August 2025
Before diving into GLP-1 vs Ozempic, let us first explore what both of them are and what actions they perform in the body
Individuals with uncontrolled hypertension, cardiovascular disease, or hyperthyroidism should avoid phentermine
Yet, I've had bouts of nausea with each of these medicines I tried